Skip to main navigation Skip to search Skip to main content

Methylation determines fibroblast activation and fibrogenesis in the kidney

  • Wibke Bechtel
  • , Scott McGoohan
  • , Elisabeth M. Zeisberg
  • , Gerhard A. Müller
  • , Hubert Kalbacher
  • , David J. Salant
  • , Claudia A. Müller
  • , Raghu Kalluri
  • , Michael Zeisberg

Research output: Contribution to journal › Article › peer-review

Abstract

Fibrogenesis is a pathological wound repair process that fails to cease, even when the initial insult has been removed. Fibroblasts are principal mediators of fibrosis, and fibroblasts from fibrotic tissues fail to return to their quiescent stage, including when cultured in vitro. In a search for underlying molecular mechanisms, we hypothesized that this perpetuation of fibrogenesis is caused by epigenetic modifications. We demonstrate here that hypermethylation of RASAL1, encoding an inhibitor of the Ras oncoprotein, is associated with the perpetuation of fibroblast activation and fibrogenesis in the kidney. RASAL1 hypermethylation is mediated by the methyltransferase Dnmt1 in renal fibrogenesis, and kidney fibrosis is ameliorated in Dnmt1 +/heterozygous mice. These studies demonstrate that epigenetic modifications may provide a molecular basis for perpetuated fibroblast activation and fibrogenesis in the kidney.

Original languageEnglish (US)
Pages (from-to)544-550
Number of pages7
JournalNature Medicine
Volume16
Issue number5
DOIs
StatePublished - May 2010
Externally publishedYes

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Methylation determines fibroblast activation and fibrogenesis in the kidney'. Together they form a unique fingerprint.

Cite this